{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T19:09:58Z","timestamp":1698692998259},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.mehy.2004.01.028","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T13:09:01Z","timestamp":1092748141000},"page":"810-812","source":"Crossref","is-referenced-by-count":4,"title":["Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs)"],"prefix":"10.1016","volume":"63","author":[{"given":"Alan","family":"Wiseman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.01.028_BIB1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/146642400312300406","article-title":"Gene therapy for diabetes","volume":"123","author":"Wiseman","year":"2003","journal-title":"J. Roy. Soc. Health"},{"key":"10.1016\/j.mehy.2004.01.028_BIB2","first-page":"10","article-title":"Circumventing chemotherapeutic resistance through cytochromes P450 isoforms","volume":"4","author":"Wiseman","year":"2003","journal-title":"J. Appl. Ther. Res"},{"key":"10.1016\/j.mehy.2004.01.028_BIB3","series-title":"Guide to cytochromes p450 structure and function","author":"Lewis","year":"2001"},{"key":"10.1016\/j.mehy.2004.01.028_BIB4","series-title":"Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding","author":"Fersht","year":"1999"},{"key":"10.1016\/j.mehy.2004.01.028_BIB5","series-title":"Enzymes: biochemistry, biotechnology, clinical chemistry","author":"Palmer","year":"2001"},{"key":"10.1016\/j.mehy.2004.01.028_BIB6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","article-title":"Heat shock proteins as regulators of the immune response","volume":"362","author":"Pockley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.01.028_BIB7","doi-asserted-by":"crossref","unstructured":"Wiseman A. Greener vaccine production with GM-yeasts 2004. Trends Biotechnol. [in press]","DOI":"10.1016\/j.tibtech.2003.10.009"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:19:52Z","timestamp":1585873192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0306987704001276"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.01.028","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}